Lihong Diao Selected Research

Rivaroxaban

1/2020

Rivaroxaban in Peripheral Artery Disease after Revascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lihong Diao Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Peripheral Arterial Disease 01/2020 - 09/2014
1	Hepatocellular Carcinoma (Hepatoma) 11/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Ischemia 01/2020
1	Myocardial Infarction 01/2020
1	Hemorrhage 01/2020
1	Ischemic Stroke 01/2020
1	Osteoporosis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Chronic Limb-Threatening Ischemia 09/2014

Drug/Important Bio-Agent (IBA)

2	ProteomeIBA 11/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
1	RivaroxabanIBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
2	Surgical Amputation (Amputations) 01/2020 - 09/2014
1	Drug Therapy (Chemotherapy) 01/2022